Home/Filings/4/0000899243-22-030186
4//SEC Filing

Boyle Kevin S. Sr. 4

Accession 0000899243-22-030186

CIK 0001107421other

Filed

Aug 31, 8:00 PM ET

Accepted

Sep 1, 4:30 PM ET

Size

5.0 KB

Accession

0000899243-22-030186

Insider Transaction Report

Form 4
Period: 2022-08-30
Boyle Kevin S. Sr.
DirectorChief Executive Officer
Transactions
  • Tax Payment

    Common Stock

    2022-08-30$2.41/sh18,750$45,188866,250 total
Footnotes (1)
  • [F1]Represents shares withheld by the Issuer to satisfy a portion of the tax withholding obligations in connection with the vesting of shares of restricted stock previously granted to the Reporting Person.

Issuer

Alaunos Therapeutics, Inc.

CIK 0001107421

Entity typeother

Related Parties

1
  • filerCIK 0001880600

Filing Metadata

Form type
4
Filed
Aug 31, 8:00 PM ET
Accepted
Sep 1, 4:30 PM ET
Size
5.0 KB